NexImmune, Inc. (NEXI)
OTCMKTS: NEXI · Delayed Price · USD
1.910
-0.260 (-11.98%)
Jul 19, 2024, 3:50 PM EDT - Market closed
NexImmune Market Cap
NexImmune has a market cap or net worth of $2.62 million as of July 22, 2024. Its market cap has decreased by -64.13% in one year.
Market Cap
2.62M
Enterprise Value
-1.85M
1-Year Change
-64.13%
Ranking
n/a
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on February 12, 2021, NexImmune's market cap has decreased from $365.85M to $2.62M, a decrease of -99.28%. That is a compound annual growth rate of -76.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2024 | 5.40M | 134.78% |
| Dec 29, 2023 | 2.30M | -63.49% |
| Dec 30, 2022 | 6.30M | -93.98% |
| Dec 31, 2021 | 104.70M | -71.38% |
| Feb 12, 2021 | 365.85M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |